Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $1.9 million.

  • Burning Rock Biotech's Net Cash Flow rose 11170.62% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 million, marking a year-over-year increase of 7236.69%. This contributed to the annual value of -$13.3 million for FY2024, which is 7002.24% up from last year.
  • As of Q3 2025, Burning Rock Biotech's Net Cash Flow stood at $1.9 million, which was up 11170.62% from -$9.4 million recorded in Q2 2025.
  • Over the past 5 years, Burning Rock Biotech's Net Cash Flow peaked at $26.1 million during Q1 2021, and registered a low of -$79.5 million during Q4 2022.
  • Moreover, its 5-year median value for Net Cash Flow was -$13.1 million (2023), whereas its average is -$15.8 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first crashed by 22521.44% in 2021, then surged by 19684.95% in 2024.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Net Cash Flow stood at -$29.2 million in 2021, then tumbled by 172.13% to -$79.5 million in 2022, then soared by 96.76% to -$2.6 million in 2023, then soared by 196.85% to $2.5 million in 2024, then fell by 23.01% to $1.9 million in 2025.
  • Its Net Cash Flow stands at $1.9 million for Q3 2025, versus -$9.4 million for Q2 2025 and -$3.5 million for Q1 2025.